Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
18.55
-1.42 (-7.11%)
May 18, 2026, 4:00 PM EDT - Market closed
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $616.4 million as of May 19, 2026.
Market Cap
616.40M
Enterprise Value
428.78M
1-Year Change
n/a
Ranking
Category
Stock Price
$18.55
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has increased from $308.79M to $616.40M, an increase of 99.62%. That is a compound annual growth rate of 111.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 616.40M | 165.85% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 728.19M |
| Relmada Therapeutics | 723.73M |
| Eikon Therapeutics | 717.34M |
| Tenax Therapeutics | 705.36M |
| Allogene Therapeutics | 690.31M |
| Solid Biosciences | 681.27M |
| BridgeBio Oncology Therapeutics | 681.08M |
| Zevra Therapeutics | 650.86M |